Multiple studies reported that HOXA5 was associated with tumor progression, including leukemia, breast cancer, lung cancer, glioblastoma, colorectal cancer, laryngeal squamous cell cancer, and liver cancer (7–9). This evidence concerns the gene HOXA5 and lung cancer.